International, Multicenter Randomized Preclinical Trials in Translational Stroke Research: It's Time to Act
Year: 2012
Type: editorial
Abstract: Translational stroke research is in a crisis, and pharmaceutical companies continue to exit the field. Many reasons for the apparently insurmountable barrier between the bench and bedside in stroke drug development have been identified. It is time to act now to bridge the gap between preclinical and clinical studies of purported new therapies. We strongly believe that it is too early to abandon translational stroke research.
Authors: Ulrich Dirnagl, Marc Fisher
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2037412522
